I’m glad you mentioned the statement from Bernie Tuch. Here is one of the things he stated.
“I am imbued with the spirit of achieving success with NTCELL in the treatment of Parkinson’s disease. If this is realized, there will be a return to shareholders, although that will take many years to achieve, with the earliest likely to be in 2027.”
2027 is 5 years away and the $15 million clinical program is not funded. If there is no genuine news flow for 5years how do you think this will ever get funded and if it does at what price?
And let’s not forget Bernie Tuch (with all due respect) is in his 70’s. He stated that he reluctantly accepted the role of interim CEO and shortly intends to stand down. So he’s admitted that he doesn’t even intend to stick around.
Ann: NEW 2022 Annual General Meeting Date, page-21
Add 1AI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.81M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $13.90K | 1.986M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 3764983 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 41489 | 1 |
View Market Depth
| Last trade - 10.57am 15/11/2024 (20 minute delay) ? |
| 1AI (ASX) Chart |